Back

epiLiver a novel tumor specific, high throughput and cost-effective blood test for specific detection of liver cancer (HCC)

2021-02-09 oncology Title + abstract only
View on medRxiv
Show abstract

Robust cost effective and high-throughput tests for early detection of cancer in otherwise healthy people could potentially revolutionize public-health and the heavy personal and public burden of the morbidity and mortality from cancer. Several studies have delineated tumor specific DNA methylation profiles that could serve as biomarkers for early detection of Hepatocellular Carcinoma (HCC) as well as other cancers in liquid biopsies. Several published DNA methylation markers fail to distinguish...

Predicted journal destinations